ADA2 was significantly increased in esophageal carcinoma (ESCA), glioblastoma multiforme (GBM), LAML, OV, PAAD, skin cutaneous melanoma (SKCM), and STAD (Figure 1D). This evidence concerns the gene ADA2 and glioblastoma.